CDKN2B-AS1 and cancer: To that end, our group previously evaluated lncRNAs in relation to chemosensitivity utilizing available data from the Genomics of Drug Sensitivity in Cancer database (GDSC) and identified significant correlations between decreased cisplatin and doxorubicin sensitivity and increased lncRNA ANRIL expression.